Mutations of the skeletal muscle acetylcholine receptor
نویسنده
چکیده
Neurology 2012;79:404–405 The skeletal muscle acetylcholine receptor (AChR) is a beautifully functional molecular complex made up of 5 subunits. Acetylcholine binding initiates pore opening, producing the endplate current (EPC); the resulting action potentials travel over the muscle surface and into the transverse tubules, initiating contraction via calcium (Ca ) release from the sarcoplasmic reticulum that interfaces with the transverse tubule network. EPC amplitude and duration is critical for proper functioning of skeletal muscle: if too small or short, it will not effectively activate sodium channels to trigger action potentials; if too long, it will trigger multiple APs. The EPC also conducts Ca into cells, so overly long EPCs will lead to endplate damage due to Ca activation of internal protease systems.1 Congenital disorders of neuromuscular transmission (CDNT), also called congenital myasthenias, allow us to explore the consequences of natural molecular experiments resulting in alteration of structure on the functioning of the AChR. The article by Shen et al.2 illustrates the importance of precise timing of the EPC and provides insights into the molecular operation of the AChR. CDNTs result from a heterogeneous group of mutations involving neuromuscular junction (NMJ) proteins.1 These syndromes usually present within the first year of life with fluctuating weakness involving limb, trunk, and axial muscles. The clinical severity of genetic disorders of the AChR reflects the extent to which the mutations are associated with failure of NMJ transmission.1,3 CDNTs involving the AChR can be associated with altered AChR kinetics, leading to either shorter or longer AChR channel openings. The longer AChR channel openings produce long duration EPCs that produce the physiologic changes that underlie the slow channel syndrome. In contrast, short duration AChR channel openings result in short duration EPCs leading to the impairments in neuromuscular transmission seen in the fast channel syndromes. In addition, mutations involving AChR subunits or molecules associated with AChR insertion or stabilization in the endplate membrane can reduce the number of endplate AChRs, reducing the total current in the EPC. Mutations involving the AChR can reduce its single channel conductance, leading to smaller EPCs or altered kinetics. The fast channel syndrome phenotypes vary depending, in part, upon whether AChR expression or single channel conductance are altered by subunit mutations.1,3 An important observation is that no AChR subunit mutations have resulted in an enhanced safety factor for neuromuscular transmission.4 The NMJ evolved over millions of years, hence it is unlikely that any mutation of NMJ components would lead to improved function. The AChR is composed of 5 subunits, 2 subunits, and 1 copy each of the , , and either the or subunit (see figure 1 of Shen et al.2). The adult form of the AChR found at the neuromuscular junction contains the subunit and the fetal or extrajunctional form of the AChR contains the subunit. The subunit contains the primary binding sites for ACh. CDNTs due to mutations of AChR subunits most commonly involve the subunit. Mutations of the subunit can result in fast channel or slow channel syndrome or disorders with reduced expression of AChRs. ACh binds in the interfaces between the and / subunits and the and subunits. The binding of 2 ACh molecules facilitates sliding or twisting of the AChR subunits, which alters the configuration of the channel pore and enables ionic current to flow.5 Studies of clinical and synthetic AChR subunit mutations have contributed greatly to the present impression, albeit incomplete, of how ACh binding facilitates subunit interactions that lead to AChR channel opening and the subunit interactions leading to channel closure.6–10 For example, the open configuration likely occurs when the AChR subunits are aligned. After both ACh molecules unbind, the AChR subunits would assume a new configuration in which the central pore is narrower. The narrowing might occur by the AChR subunits twisting together,
منابع مشابه
MUSCARINIC RECEPTOR SUBTYPES IN SMOOTH MUSCLE FROM THE BODY OF HUMAN STOMACH
Up to date, there are four pharmacologically characterized subtypes of muscarinic receptors (M1, M2, M3 and M4). In our study we have investigated muscarinic receptor subtypes in smooth muscle layers of human stomach. Isolated preparations of longitudinal and circular muscle layers from human stomach were used. Acetylcholine, bethanechol, carbachol, pilocarpine and AHR -602 produced concen...
متن کاملCongenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.
The congenital myasthenic syndromes (CMS) are a diverse group of genetic disorders caused by abnormal signal transmission at the motor endplate, a special synaptic contact between motor axons and each skeletal muscle fibre. Most CMS stem from molecular defects in the muscle nicotinic acetylcholine receptor, but they can also be caused by mutations in presynaptic proteins, mutations in proteins ...
متن کاملLrp4 Is a Receptor for Agrin and Forms a Complex with MuSK
Neuromuscular synapse formation requires a complex exchange of signals between motor neurons and skeletal muscle fibers, leading to the accumulation of postsynaptic proteins, including acetylcholine receptors in the muscle membrane and specialized release sites, or active zones in the presynaptic nerve terminal. MuSK, a receptor tyrosine kinase that is expressed in skeletal muscle, and Agrin, a...
متن کاملبررسی اثر دیفن هیدرامین بر انتقال عصبی - عضلانی عضله دو بطنی گردن جوجه
Background and purpose: Diphenhydramine, an ethanolamine derivative, is a histamine H1 receptor antagonist. This drug is usually used for symptomatic relief of hypersensitivity reactions including: urticaria, angioedema, rhinitis, conjunctivitis and pruritic skin disorders. Ïn addition, diphenhydramine is also used in the treatment of nausea, vomiting, motion sickness, vertigo, sleepless ness...
متن کاملSequential expression of three receptor subtypes for extracellular ATP in developing rat skeletal muscle.
In this study, we investigated the expression of the P2X receptor subtypes (P2X(1-7)) during the development of skeletal muscle and in relation to acetylcholine receptors in the rat embryo and pup. By using immunohistochemistry, we showed that three receptor subtypes, P2X(2), P2X(5), and P2X(6), were expressed in developing skeletal muscle. The timing and pattern of receptor expression seemed t...
متن کامل